OIC Associate Hector Edwards Discusses Medtech Financing Risk and Rewards in the FT’s PWM
A historical cycle of scarcity and survival presents an opportunity for outsized returns in the often misunderstood medical technology investment market.
A historical cycle of scarcity and survival presents an opportunity for outsized returns in the often misunderstood medical technology investment market.
OIC Founding Partner George Robinson joins the Oxford+ Podcast to discuss risk, reward, and the realities of investing in early-stage tech.
“What’s changed in the last 10 years is that we’ve got much better at commercialising science ourselves. We have a culture of entrepreneurship now. It’s now not just acceptable, but encouraged for academics to become entrepreneurs.”
Christopher tells us about how he is applying his experience in law and corporate finance to early-stage tech investment in Oxford.
George tells us a little about his career, how he came to work with Oxford spinouts and some advice he has for venture-backed businesses.